Afferent Pharmaceuticals, Inc.

ACTIVE

2929 Campus Dr Ste 230, 加利福尼亚州圣马特奥县, California, United Stateswww.afferentpharma.comSubsidiary11–50 employeesEstablished: 2009-01-01

Part of 默沙东

Clinical Trials

6 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2009

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

66.7%

Trial Status Distribution

Active, not recruiting

100.0%

Clinical Trials

Trials sponsored by this organization (6)

A 12 week study to assess the efficacy and safety of AF-219 in patients with long term cough

Phase 1

Active, not recruiting

Dec 2015253 participants

A study to determine the effect of AF-219 on the urge to cough in patients with long-term cough

Phase 1

Active, not recruiting

Jul 201536 participants

A study to determine the ability of AF-219 to affect the cough reflex in healthy volunteers and in people affected by long-term coughing

Phase 1

Active, not recruiting

Mar 201550 participants

A study to assess the efficacy and tolerance of AF-219 in patients with long term cough

Phase 1

Active, not recruiting

Mar 201559 participants

A study of the effects of AF-219 on airway hyper-reactivity in asthma.

Active, not recruiting

Dec 201320 participants

A study of investigational drug AF-219 and its affect on treating subjects with chronic cough

Active, not recruiting

Feb 201125 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations